Table 1 Number of study subjects and timing of post treatment assessment in studies using DASH and reporting pre- and post-operative data)
Author | No. study subjects | Assessment schedule (range) | Pre-op | Post-op (final) |
|---|---|---|---|---|
Mean (range/ SD) | Mean (SD) | |||
Engstrand et al. | 60 | Pre and 3 months | 17 (7–28) | 7 (3–12 interquartiles) |
Herweijer* | 46 | Pre and mean 10 (7 to 13) months | 12.1 (12.9) | 6.6 (8.8) |
Jerosch-Herold, | 148 | Pre, 3, 6 and 12 months | 16.4 (15.1) Splint group | 7 (14.6) Splint group |
15.4 (13.2) No Splint group | 6 (9.2) No Splint group | |||
Johnston et al. * | 17 pre-op and 16 post-op | Pre, 3 and mean of 14 (11 to 16) months | 24 (20) | 8(8) |
Skoff, | 30 (cohort of 10 and 20 subjects respectively) | Pre and average of 42 (37 to 48) months for cohort of 10 subjects. Pre and average 32 (range 24 to 36) months for cohort of 20 subjects. | 37 ‘mild disability’ raw data | 30 ‘no self-perceived disability’ raw data |
Sobierajska | 35 | Pre, 1 and 3 months | 17.5 (14.88) | 15.02 (15.25) |
Van Rijssen (a), | 50 PNF | Pre, 1,2,3,4 and 5 weeks | 16 (14) PNF group | 9 PNF group |
47 LF | 14 (12) LF group | 16 LF group | ||
Zyluk | 54 | Pre, 3 and 12 months | 54 (30 to 103) raw data | 32 (30 to 104) raw data |